A bone marrow transplant process co-developed by investigators at the Johns Hopkins Kimmel Cancer Center is safe and curative ...

A new type of bone marrow transplant can cure sickle cell disease with only half of the donor's cell proteins matching, ...

When Vijay Sankaran was an MD-PhD student at Harvard Medical School in the mid-2000s, one of his first clinical encounters ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

Esther Nkemakolam runs her fingers through kinetic sand and sings a “Moana” song as UPMC Children’s Hospital nurse Taylor ...

Sickle cell disease (SCD), the most common inherited blood disorder, affects millions worldwide. In the United States alone, ...

A new bone marrow transplant method can help cure sickle cell disease and is more accessible than highly expensive gene ...

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.

The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through ...

The underutilization of disease-modifying therapy by people with sickle cell disease is “persistent and alarming,” according ...

Grant Sickle Cell Center to help treat those ... facility in South Carolina to offer the newest disease-modifying therapies, including gene therapy. “Gene therapy is we collect the cells through ...

Bluebird Bio, Inc. (NASDAQ:BLUE), on Friday, entered into a definitive agreement to be acquired by global investment firms ...